TNF and COVID-19: When not inhibited by TIMP-3, due to low SIRT1 activity-mediated TIMP-3 reduction, ADAM17 causes the release of TNF-α and IL6 and contributes to inflammation and possibly to the development of an uncontrolled hyperinflammatory response in COVID-19 [98,101].